Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Trop ; 178: 107-114, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29113781

ABSTRACT

The progression of Chagas disease (CD) varies significantly from host to host and is affected by multiple factors. In particular, mixed strain infections and reinfections have the potential to exacerbate disease progression subsequently affecting clinical management of patients with CD. Consequently, an associated reduction in therapeutic intervention and poor prognosis may occur due to this exacerbated disease state. This study investigated the effects of mixed strain infections and reinfection with Trypanosoma cruzi in mice, using two isolates from different discrete typing units, TcI (C8 clone 1) and TcIV (10R26). There were no significant differences in mortality rate, body weight or body condition among mice infected with either C8 clone 1, 10R26, or a mixture of both isolates. However, the parasite was found in a significantly greater number of host organs in mice infected with a mixture of isolates, and the histopathological response to infection was significantly greater in mice infected with C8 clone 1 alone, and C8 clone 1+10R26 mixed infections than in mice infected with 10R26 alone. To investigate the effects of reinfection, mice received either a double exposure to C8 clone 1; a double exposure to 10R26; exposure to C8 clone 1 followed by 10R26; or exposure to 10R26 followed by C8 clone 1. Compared to single infection groups, mortality was significantly increased, while survival time, body weight and body condition were all significantly decreased across all reinfection groups, with no significant differences among these groups. The mortality rate over all reinfection groups was 63.6%, compared to 0% in single infection groups, however there was no evidence of a greater histopathological response to infection. These results suggest firstly, that the C8 clone 1 isolate is more virulent than the 10R26 isolate, and secondly, that a more disseminated infection may occur with a mixture of isolates than with single isolates, although there is no evidence that mixed infections have a greater pathological effect. By contrast, reinfections do have major effects on host survivability and thus disease outcome. This confirms previous research demonstrating spontaneous deaths following reinfection, a phenomenon that to our knowledge has only been reported once before.


Subject(s)
Chagas Disease/mortality , Chagas Disease/veterinary , Trypanosoma cruzi/genetics , Animals , Coinfection/parasitology , Disease Progression , Humans , Male , Mice , Trypanosoma cruzi/isolation & purification
2.
Future Med Chem ; 5(15): 1733-52, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24144410

ABSTRACT

BACKGROUND: Inhibitors of Trypanosoma cruzi with novel mechanisms of action are urgently required to diversify the current clinical and preclinical pipelines. Increasing the number and diversity of hits available for assessment at the beginning of the discovery process will help to achieve this aim. RESULTS: We report the evaluation of multiple hits generated from a high-throughput screen to identify inhibitors of T. cruzi and from these studies the discovery of two novel series currently in lead optimization. Lead compounds from these series potently and selectively inhibit growth of T. cruzi in vitro and the most advanced compound is orally active in a subchronic mouse model of T. cruzi infection. CONCLUSION: High-throughput screening of novel compound collections has an important role to play in diversifying the trypanosomatid drug discovery portfolio. A new T. cruzi inhibitor series with good drug-like properties and promising in vivo efficacy has been identified through this process.


Subject(s)
Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Administration, Oral , Animals , Cell Line , Cell Survival/drug effects , Chagas Disease/drug therapy , Chagas Disease/mortality , Cytochrome P-450 CYP3A/metabolism , Cytochrome P-450 CYP3A Inhibitors , Disease Models, Animal , High-Throughput Screening Assays , Humans , Mice , Parasitic Sensitivity Tests , Rats , Structure-Activity Relationship , Survival Rate , Time Factors , Trypanocidal Agents/chemistry , Trypanocidal Agents/therapeutic use
3.
Plant Cell Physiol ; 45(12): 1875-81, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15653807

ABSTRACT

The Arabidopsis proline-rich extensin-like receptor kinase (PERK) family consists of 15 predicted receptor kinases. A comprehensive expression analysis was undertaken to identify overlapping and unique expression patterns within this family relative to their phylogeny. Three different approaches were used to study AtPERK gene family expression, and included analyses of the EST, MPSS and NASCArrays databases as well as experimental RNA blot analyses. Some of the AtPERK members were identified as tissue-specific genes while others were more broadly expressed. While in some cases there was a good association between these different expression patterns and the position of the AtPERK members in the kinase phylogeny, in other cases divergence of expression patterns was seen. The PERK expression data identified by the bioinformatics and experimental approaches were found generally to show similar trends and supported the use of data from large-scale expression studies for obtaining preliminary expression data. Thus, the bioinformatics survey for ESTs and microarrays is a powerful comprehensive approach for obtaining a genome-wide view of genes in a multigene family.


Subject(s)
Arabidopsis Proteins/genetics , Arabidopsis/genetics , Phosphotransferases/genetics , Arabidopsis/enzymology , Arabidopsis Proteins/metabolism , Computational Biology , Gene Expression Profiling/methods , Gene Expression Regulation, Plant/genetics , Genome, Plant , Multigene Family , Phosphotransferases/metabolism , Phylogeny , Proline/metabolism , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...